Artivion | CRY - Себестоимость





Себестоимость Изменить Дата
Abbott USD 5.94B 642M 2026-06
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 34.98M 3.04M 2026-06
Baxter International USD 1.93B 118M 2026-06
Becton, Dickinson and Co. USD 2.56B 281M 2026-03
Boston Scientific USD 1.86B 29M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Inogen USD 39.59M 1.27M 2024-09
Integra LifeSciences USD 188.86M 10.15M 2026-06
J&J USD 8B 67M 2026-06
Mesa Laboratories USD 21.92M 1.78M 2024-09
Orthofix International USD 66.63M 6.4M 2025-12
Pfizer USD 4.59B 1.7B 2026-03
ResMed USD 551.67M 4.17M 2026-03
Stryker USD 2.26B 106M 2026-06
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 240.84M 20.7M 2026-03
Terumo JPY 151.3B 7.86B 2026-03
Trinity Biotech USD 7.17M 666K 2025-12